Infant liquid ibuprofen recalled over safety concerns, sold at Walmart, CVS, Family Dollar | 6abc.com - 6abc Action News

https://6abc.com/health/infant-liquid-ibuprofen-recalled-over-safety.../5114079/

10/18/2018

3013438582

Denver Solutions, LLC dba Leiter's Health

FMD-145 Letter

CO

Outsourcing Facility

01/28/2019

11/14/2018

3003637491

Duren’s Health Mart Pharmacy

483

TN

Producer of Sterile Drug Products

01/28/2019

11/29/2018

3008563008

Exela Pharma Sciences LLC

FMD-145 Letter

NC

Outsourcing Facility

01/28/2019

11/14/2018

3014745182

Hiers Enterprises, LLC dba Northwest Compounding Pharmacy

483

OR

Producer of Sterile Drug Products

01/28/2019

12/26/2018

3014549940

Good Health, Inc. DBA Premier Pharmacy Services

483

CA

Producer of Sterile Drug Products

01/28/2019

12/14/2018

Hangzhou Guoguang Touring Commodity Co.,Ltd.

Center for Drug Evaluation and Research

CGMP/Finished Pharmaceuticals/Adulterated

Not Issued *

Statement from FDA Commissioner Scott Gottlieb, M.D., on 2019 efforts to advance the development of complex generics to improve patient access to medicines

As part of the FDA’s efforts to promote drug competition and patient access, we’ve advanced many policies aimed at making it more efficient to bring generic competition to the market. We’ve been especially focused on a category of medicines known as complex drugs. These are drugs that, by nature of their formulation, delivery systems or the complexity of their active ingredients, for example, are harder to ...

Athens County Farmer Pleads Guilty to Having Contaminated Calf Slaughtered for Beef

	CINCINNATI – Cory L. Gillette, 31, of Albany, Ohio, pleaded guilty in U.S. District Court to having a medicated calf slaughtered with the intention of selling it as beef for human consumption. The calf was contaminated with Gentamicin, which is not approved for use in cattle. Continue reading.

To close out 2018, FDA published a revised draft guidance on human ...

Lexology-1 hour ago

In accordance with the United States Food & Drug Administration's (“FDA”) 2018 Compounding Policy Priorities Plan, on December 11, 2018, FDA published its .